These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mechanism of hyperthermia in the interaction between pethidine or imipramine and monoamine oxidase inhibitors. Gong NC, Rogers KJ. Med J Malaysia; 1973 Jun; 27(4):280-3. PubMed ID: 4270786 [No Abstract] [Full Text] [Related]
4. Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study. Rabkin J, Quitkin F, Harrison W, Tricamo E, McGrath P. J Clin Psychopharmacol; 1984 Oct; 4(5):270-8. PubMed ID: 6386898 [Abstract] [Full Text] [Related]
5. Differential response patterns to MAO inhibitors and tricyclics. Nies A. J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487 [Abstract] [Full Text] [Related]
8. Effect of chlorpromazine, imipramine and lithium on MAO-A and MAO-B activity in rat brain mitochondria. Nag M. Indian J Exp Biol; 2004 Sep; 42(9):941-4. PubMed ID: 15462192 [Abstract] [Full Text] [Related]
15. Monoamine oxidase inhibitors: have they a place, have they a future? Pollitt J. Br J Hosp Med; 1987 Dec; 38(6):564-5. PubMed ID: 3325126 [Abstract] [Full Text] [Related]
16. Monoamino oxidase inhibitors and schizophrenia. Bucci L. Dis Nerv Syst; 1967 Jan; 28(1):55-9. PubMed ID: 5334844 [No Abstract] [Full Text] [Related]
17. Successful treatment of the toxic serotonin syndrome with chlorpromazine. Graham PM. Med J Aust; 1997 Feb 03; 166(3):166-7. PubMed ID: 9059446 [No Abstract] [Full Text] [Related]